newsfilter
← Latest News
PR Newswire·

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Movano Health (Nasdaq: MOVE) announced today that a productive in-person meeting with the FDA on August 15, 2024, resulted in a positive outcome...